Thus, breast tumors have been classified into four categories (luminal A, luminal B, Her2 and triple-negative) on the basis of the immunohistochemical detection of estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor type II receptor (HER2). Here, ESR1 is linked to breast neoplasm.